Summary of COVID-19 vaccine-related erythema multiforme at Kin-dai University Hospital, Japan
Trends in Immunotherapy
; 6(2):40-42, 2022.
Article
in English
| Scopus | ID: covidwho-2226563
ABSTRACT
The recently extended use of mRNA vaccines due to the COVID-19 pandemic has allowed the description of mul-tiple cutaneous adverse events including local injection site reactions, urticaria, and morbilliform eruptions. COVID-19 vaccine-related cutaneous reaction patterns can be divided into type Ⅰ hypersensitivity reactions, type Ⅳ hypersensitivity reactions, autoimmune-related, and functional angiopathies based on pathogenesis. Erythema multiforme (EM), a type IV hypersensitivity reaction, has also been reported from several centers. We experienced the remarkable im-provement of COVID-19 vaccine-related EM with systemic administration of prednisolone and summarized six cases experienced in our department. © 2022 Keiko Watanabe, et al. EnPress Publisher LLC. This work is li-.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Topics:
Vaccines
Language:
English
Journal:
Trends in Immunotherapy
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS